Corporate ManufacturerCached Profile
REGENERON PHARMACEUTICALS
Manufacturer Corporate ID: 100000000069
Subsidiaries Logged: 1 entities
LIFETIME CORPORATE SPEND
$6,095,278
General Payments Aggregated (2021–2025)
Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.
Top Funded Physicians
Physicians receiving the highest promotional payments from this corporation.
1. Dr. JOSEPH GOLDSTEINMedical Doctor
$1,010,9842. Dr. MICHAEL BROWNMedical Doctor
$674,9873. Dr. CRAIG THOMPSONMedical Doctor
$569,2424. Dr. DAVID SCHENKEINMedical Doctor
$263,4445. Dr. ANDREW JIMedical Doctor
$250,000Top Promoted Products
Drugs or medical devices receiving the highest marketing backing.
1. DUPIXENT$659,351 (10.8%)
2. LIBTAYO$560,080 (9.2%)
3. EYLEA$327,571 (5.4%)
4. EYLEA HD$110,577 (1.8%)
5. EVKEEZA$39,695 (0.7%)
Active Subsidiary Entities
Corporate subsidiaries and brands associated with this manufacturer ID in Open Payments.
REGENERON PHARMACEUTICALS, INC.
Corporate General Payouts Log
Federal registry records of promotional speaking, consulting, meals, and offsets.
Year:
2025
2025
2024
2023
2022
2021
Querying Open Payments Database
Fetching live CMS.gov records for REGENERON PHARMACEUTICALS...